Hyogo Naoi
Hamamatsu, 4313192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Myeloperoxidase promotes fibrosis by inhibiting cathepsin K to bias the lung toward ECM accumulation.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis.
Journal: Scientific reports
Published: June 22, 2025
Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia.
Journal: Scientific reports
Published: August 08, 2024
CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort study.
Journal: Respiratory research
Published: July 16, 2024
Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort study.
Journal: Respiratory medicine
Published: December 30, 2023
CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 25, 2023
Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases.
Journal: BMC pulmonary medicine
Published: August 26, 2022
Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
Journal: Thorax
Published: September 27, 2021
Last Updated: 09/26/2026